The LIFT Study is available nationwide to TrialNet participants who either:
Developed diabetes while being monitored in the Pathway to Prevention Study or during participation in any prevention trial. The purpose is to study people early in the disease process
Participated in any new onset studies. The purpose is to learn more about diabetes and if there are any long-term effects—good or bad—from the treatments used in these studies
Participants will be asked to return to a TrialNet site annually or semi- annually, based on their ongoing ability to produce insulin. Visits will include metabolic testing (i.e., Oral Glucose Tolerance Test and/or Mixed Meal Tolerance Test), HbAc1, and possibly other blood or urine tests.
To study subjects early in the Type 1 Diabetes process, and to study if there are any long-term effects from the treatments used in previous new onset studies.
Inclusion Criteria:
Subjects that were previously enrolled in a TrialNet study for people newly diagnosed with type 1 diabetes
Subjects that developed type 1 diabetes while participating in the Pathway to Prevention Study or a TrialNet prevention study.
This study is ongoing.
Diabetes
Observational
Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
Division of Diabetes, Endocrinology, and Metabolic Diseases
Dataset Name | Description | # of Records | # of Variables | File Format(s) |
---|---|---|---|---|
Change of Status Dataset | Captures data on change of participant enrollment status | 306 | sas7bdat (1.5 MB); csv (49.38 KB) | |
Variable Names
| ||||
Adverse Events Review Dataset | Data collected on the review of adverse event information | 7 | sas7bdat (1 MB); csv (912 B) | |
Adverse Events Dataset | Any unfavorable and unintended sign, symptom, or disease associated with medical treatment or procedure | 18 | sas7bdat (1 MB); csv (10.54 KB) | |
Protocol Deviations Dataset | Protocol deviation procedures recorded during participant visits | 186 | sas7bdat (1.48 MB); csv (63.29 KB) | |
Eligibility Form Dataset | Eligibility form data describing participant consent and involved trial | 557 | sas7bdat (1 MB); csv (46.49 KB) | |
Participant Registration Dataset | Data collected on participant registration and status | 561 | sas7bdat (1 MB); csv (21.34 KB) | |
Concomitant Medication Data Dataset | Information data regarding type of medication, amount of medication, indication, etc. | 1538 | sas7bdat (2.5 MB); csv (167.7 KB) | |
Permanent Site Transfer Dataset | Data collected on participant permanent site transfer and reason for transfer | 48 | sas7bdat (1 MB); csv (5.96 KB) | |
Diabetes Health Information Dataset | Data collected on the health information of participants with diabetes | 2596 | sas7bdat (3.45 MB); csv (545.09 KB) | |
Physical Exam Dataset | Data collected on physical exam performed on patient | 2 | sas7bdat (1 MB); csv (797 B) | |
Research Labs Dataset | Specimen collection, test results, and sample identification data | 38895 | sas7bdat (61 MB); csv (5.81 MB) | |
Protocol Versions Used Dataset | Specific protocol versions used during participant visits | 636 | sas7bdat (1 MB); csv (25.93 KB) | |
Health Status Request Dataset | Captures data on participant health status | 31 | sas7bdat (1 MB); csv (12.03 KB) |
Specimen | Count |
---|---|
PB-PBMC | 9306 |
Plasma | 13552 |
Serum | 4889 |
Whole Blood | 2998 |